Concepedia

Göran FH Hansson

GF

Statistics

Publications

3

Citations

60

H-Index

3

Active since

2003

Affiliations

AstraZeneca (Sweden)(Current)

Göran FH Hansson is an author at AstraZeneca (Sweden) specializing in pharmacology, antithrombotic therapy, and anticoagulant therapy.

Publications per year

2003–2004

3

Publications

3

Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects

Stig Boström, Göran FH Hansson, Troy C. Sarich · Blood Coagulation & Fibrinolysis · 2003 · 31 citations

, , +17

The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma

Stig Boström, Göran FH Hansson, Troy C. Sarich et al. · Thrombosis Research · 2004 · 18 citations

, , +14

Inhibition of thrombin-induced feedback activation of factor V

Stig Boström, Emelie Dagnelid, Göran FH Hansson et al. · Blood Coagulation & Fibrinolysis · 2004 · 11 citations

, , +17

1–3 of 3